1. Home
  2. VCYT vs KLRA Comparison

VCYT vs KLRA Comparison

Compare VCYT & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$51.41

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$0.00

Market Cap

2.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VCYT
KLRA
Founded
2006
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.5B
IPO Year
2013
2026

Fundamental Metrics

Financial Performance
Metric
VCYT
KLRA
Price
$51.41
N/A
Analyst Decision
Strong Buy
Analyst Count
7
0
Target Price
$44.00
N/A
AVG Volume (30 Days)
1.2M
N/A
Earning Date
05-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
164.52
N/A
EPS
0.35
N/A
Revenue
N/A
N/A
Revenue This Year
$13.76
N/A
Revenue Next Year
$12.35
N/A
P/E Ratio
$145.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.61
N/A
52 Week High
$52.45
N/A

Technical Indicators

Market Signals
Indicator
VCYT
KLRA
Relative Strength Index (RSI) 68.75 N/A
Support Level $40.27 N/A
Resistance Level N/A N/A
Average True Range (ATR) 2.41 0.00
MACD -0.11 0.00
Stochastic Oscillator 80.07 0.00

Price Performance

Historical Comparison
VCYT
KLRA

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: